Binding of CXCL12 to CXCR4 has been shown toincrease cellular secretion of VEGF in ovarian cancer [150], breast cancer [147],prostate cancer [149, 151], and malignant glioma [152]. Here, CXCL12 is linked to prostate carcinoma.